Articles related to QUALITY OF LIFE

In a 3-year randomized clinical trial, dialectical behavior therapy and schema therapy produced substantial improvements in borderline personality disorder severity. No statistically significant differences were observed between treatments on primary or secondary outcomes.

Fluvoxamine reduced fatigue and improved quality-of-life measures in adults with long COVID in a randomized placebo-controlled trial. The findings provide evidence for a potential therapy, although further research is needed to define optimal patient selection and treatment strategies.

Patients treated by advanced nurse practitioners in an Irish emergency department injuries service reported high levels of satisfaction and patient enablement. Communication quality was associated with both outcomes, although the study design did not establish causality.

An 8-week observational study of young adults with acne found significant improvements in both acne severity and dermatology-related quality of life. Improvements in clinical grading did not correlate with patient-reported quality-of-life gains, highlighting the multidimensional impact of acne.

A case-based application of FRESCO trial data positions fruquintinib as a third-line option in KRAS-mutant metastatic colorectal cancer, while emphasizing treatment decisions shift toward disease control and quality of life after multiple prior lines.

Primary trabeculectomy reduced the rate of visual field loss by approximately 50% compared with a medications-first approach in newly diagnosed advanced open-angle glaucoma patients across a 5-year randomized trial, though standard quality-of-life instruments failed to detect that clinical benefit.